3 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 3 |
Follow Pravat Mandal: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients Gamma- Glutamylcysteine, Gamma- Glutamylcusteine - Mild Cognitive Impairment (MCI) | Phase 1 | Recruiting | Pravat Mandal | 9 | 2026-08-04 | 2026-08-07 |
| Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation Gamma-glutamylcysteine (GGC) - Repetitive Head Impacts | Phase 1 | Recruiting | Pravat Mandal | 30 | 2026-05-01 | 2026-06-03 |
| Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients. Gamma- glutamylcysteine - Parkinsons Disease (PD) | Phase 1 | Recruiting | Pravat Mandal | 12 | 2026-03-23 | 2026-05-04 |
Brain Injuries (1) · Cognitive Dysfunction (1) · Parkinson Disease (1)
United States (3)
Pravat K Mandal, PHD (1) · Pravat K Mandal, PhD (1)
2001 (1)